The daunting reality for thousands of individuals is that a diagnosis of end-stage liver failure begins a desperate race against time, a wait for a life-saving organ that, for many, will never arrive. This critical shortage of donor organs has created a persistent crisis in modern medicine, with
Today we are speaking with Ivan Kairatov, a biopharma expert whose work at the intersection of public health and cancer epidemiology sheds light on one of the world’s most preventable cancers. We’ll be exploring the complex story behind cervical cancer: a disease for which we have the tools to
A comprehensive systematic review and meta-analysis led by researchers at the Icahn School of Medicine at Mount Sinai has established a significant association between exposure to per- and polyfluoroalkyl substances and an increased risk of gestational diabetes mellitus, alongside altered markers
Biopharma expert Ivan Kairatov joins us to discuss a groundbreaking advance in immunotherapy. While treatments like CAR-T cell therapy have shown incredible promise, they are not a solution for every patient, often because the necessary immune cells are rare or difficult to work with. Now,
A groundbreaking discovery has unveiled a class of small molecules that effectively teach the body to eliminate its own disease-causing components, a development that could rewrite the rules for treating some of the most stubborn medical conditions. An international team of scientists has
With over two decades of research in biopharma, Ivan Kairatov has witnessed the evolution of microbiome science from a niche interest into a central player in our understanding of health. As an expert in R&D and technological innovation, he has a unique perspective on the translational gap—the
